Precision medicine research on chemo-immunotherapy combination treatment for locally advanced or metastatic non-small cell lung cancer based on deep plasma proteomics.
Qiuchi Chen(Union Hospital), Xiaorong Dong(Union Hospital), Yawen Bin(Union Hospital), Yi Zeng(Duke University), Meng Xu(Beijing Proteome Research Center), Xiaobo Yu(Beijing Proteome Research Center), Rui Zhou(Shanghai University of Traditional Chinese Medicine), Ling Peng(Guangzhou University of Chinese Medicine), Zuo Wang(Shanghai University of Engineering Science), Fan Tong(Union Hospital), Jieying Zhang(Union Hospital), Hongxia Zhou, Xiaomei Zhang(Tang Hospital), Ruiguang Zhang(Union Hospital), Qiaoyun Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhongyuan Yin(Union Hospital)
Cited by 0
Related Papers
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
|Clinical Infectious Diseases|2020|1.1k
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
|Journal of Allergy and Clinical Immunology|2020|694